Bradley J. Bolzon Ph.D., Director, 10% Owner at Black Diamond Therapeutics, Inc. (BDTX), sold 260,034 shares at $33.01 ($8.6M) on 2020-11-19, disclosed to the SEC on 2020-11-23.
Open-market sale of $8.6M BDTX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.01 | 15,163 | $501K | 5.8% |
| 2 | $33.01 | 15,163 | $501K | 5.8% |
| 3 | $33.01 | 114,854 | $3.8M | 44.2% |
| 4 | $33.01 | 114,854 | $3.8M | 44.2% |
| Total | $33.01 avg | 260,034 | $8.6M | 100% |
| Filing → |
| CRSP | SELL | 2021-06-30 | $14.1M | — | Filing → |
| CRSP | SELL | 2021-06-30 | $9.2M | — | Filing → |
| CRSP | SELL | 2021-06-15 | $2.3M | — | Filing → |